Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study
Abstract Aims We aim to evaluate change in the use of prognostic guideline‐directed medical therapies (GDMTs) for heart failure (HF) before and after a cancer diagnosis as well as the matched non‐cancer controls, including renin‐angiotensin‐system inhibitors (RASIs), beta‐blockers, and mineralocorti...
Saved in:
| Main Authors: | Chengsheng Ju, Wallis C.Y. Lau, Charlotte Manisty, Pinkie Chambers, Ruth Brauer, Martin D. Forster, Isla S. Mackenzie, Li Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.14981 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends and influencing factors of self-management in patients with chronic heart failure: a longitudinal study
by: Wen Ding, et al.
Published: (2025-04-01) -
NON-PHARMACOLOGICAL INTERVENTIONS IN HEART FAILURE PATIENTS TO IMPROVE SLEEP QUALITY
by: Rosiah Rosiah
Published: (2022-05-01) -
Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01) -
A longitudinal study of changes in depressive symptoms and risk factors for congestive heart failure
by: Julia Gallucci, et al.
Published: (2025-05-01) -
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
by: Charlotte Nordberg Backelin, et al.
Published: (2020-06-01)